Arcus Biosciences, Inc. revenue breakdown overview

Arcus Biosciences, Inc. revenue for the last year amounted to 258.00 M USD, the most of which — 258.00 M USD — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 117.00 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arcus Biosciences, Inc. 258.00 M USD, and the year before that — 117.00 M USD.